Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.
Clazinus VeijerMarinus H van HulstBenjamin FriedrichsonMaarten Jacobus PostmaAntoinette D I van AsseltPublished in: PharmacoEconomics (2024)
Protocol registered in PROSPERO under CRD42023407646.